Invention Grant
- Patent Title: Heterocyclic compounds as bromodomain inhibitors
-
Application No.: US15424616Application Date: 2017-02-03
-
Publication No.: US09861637B2Publication Date: 2018-01-09
- Inventor: Shuang Liu , Bryan Cordell Duffy , John Frederick Quinn , May Xiaowu Jiang , Ruifang Wang , Gregory Scott Martin , He Zhao , Bruce Francis Molino , Peter Ronald Young
- Applicant: Zenith Epigenetics Ltd.
- Applicant Address: CA Calgary, AB
- Assignee: Zenith Epigenetics Ltd.
- Current Assignee: Zenith Epigenetics Ltd.
- Current Assignee Address: CA Calgary, AB
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/501 ; A61K31/506 ; A61K31/4439 ; A61K31/497 ; A61K31/513 ; A61K31/4545 ; A61K31/50 ; A61K31/498 ; A61K31/4709 ; A61K31/444 ; A61K31/4412 ; A61K31/496 ; A61K31/472 ; A61K31/502 ; A61K31/4725 ; A61K31/4375
Abstract:
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Public/Granted literature
- US20170143731A1 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS Public/Granted day:2017-05-25
Information query
IPC分类:
